These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21636813)

  • 1. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.
    Adeoye O; Hornung R; Khatri P; Kleindorfer D
    Stroke; 2011 Jul; 42(7):1952-5. PubMed ID: 21636813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
    Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
    J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
    Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
    Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
    Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
    Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
    Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
    Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy.
    Knisely K; Sanders CB; Edrissi C; Rathfoot C; Poupore N; Bailey-Taylor MJ; Stewart B; Nathaniel T
    J Vasc Nurs; 2022 Jun; 40(2):74-85. PubMed ID: 35750378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007.
    Hoh BL; Chi YY; Waters MF; Mocco J; Barker FG
    Stroke; 2010 Oct; 41(10):2323-8. PubMed ID: 20724715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
    Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
    Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity.
    Blum B; Penwell A; Wormack L; Walker B; Lari S; Nathaniel TI
    Neurol Sci; 2019 Sep; 40(9):1829-1839. PubMed ID: 31049791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
    Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
    Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Yang Y; Liu B; Wu L; Guan X; Luo Y; Jiang C; Gupta S; Huang Z; Everett G
    Cerebrovasc Dis; 2019; 48(3-6):157-164. PubMed ID: 31694030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive.
    Kerr DM; Fulton RL; Higgins P; Bath PM; Shuaib A; Lyden P; Lees KR;
    Stroke; 2012 Feb; 43(2):399-404. PubMed ID: 22075999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
    Khedr EM; Abdelwarith A; Moussa G; Saber M
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
    Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
    Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.